In NSCLC cells, p45AUF1 is increased by the chemotherapeutic agent, prostaglandin A2, and this induction increases Cyclin D1 mRNA turnover by binding the Cyclin D1 3′-UTR [87]. This evidence concerns the gene CCND1 and non-small cell lung carcinoma.